by ADRIAN FREDERICK MANZ Manz | Aug 25, 2025 | The Doctor's Dose
Nvidia Jetson AGX Thor Robot Brain: A Fresh Catalyst for NVDA Nvidia’s new Nvidia Jetson AGX Thor robot brain platform—built on Blackwell—arrives with developer kits at $3,499 and production Jetson T5000 modules for scaled deployments. What launched—and why it matters...
by ADRIAN FREDERICK MANZ Manz | Aug 25, 2025 | The Doctor's Dose
Tesla Stock Soars on Rate‑Cut Hopes (Aug 2025) Powell’s Jackson Hole remarks pushed rate‑cut odds higher and lifted risk assets—TSLA included. Meanwhile, Tesla’s new Cybertruck Luxe Package grabbed headlines but remains a sideshow to the rates story. Overview · Rates...
by ADRIAN FREDERICK MANZ Manz | Aug 24, 2025 | The Doctor's Dose
Week Ahead: Nvidia earnings and PCE inflation gauge (Aug 25–29, 2025) In the wake of Fed Chair Jerome Powell’s Jackson Hole remarks, markets face a packed slate of economic data and high‑impact earnings—headlined by the Fed’s preferred inflation measure and Nvidia’s...
by ADRIAN FREDERICK MANZ Manz | Aug 23, 2025 | The Doctor's Dose
Japanese Stocks Soar Despite Tariffs and Turmoil (Aug 2025) EWJ and key indices in Tokyo keep climbing even as the U.S. locks in 15% reciprocal tariffs and Japan’s ruling coalition loses its upper‑house majority. Here’s what’s driving the rally—and how to trade it....
by ADRIAN FREDERICK MANZ Manz | Aug 20, 2025 | The Doctor's Dose
Estée Lauder Stock Plummets: Weak Guidance Spooks Investors Estée Lauder stock (EL) plummets after the cosmetics giant reported in-line earnings but issued soft guidance for the fiscal year ahead. Despite adjusted EPS of $0.09 on revenue of $3.41B—both in line with...
by ADRIAN FREDERICK MANZ Manz | Aug 20, 2025 | The Doctor's Dose
Target CEO Change Overshadows Earnings: What Day Traders Should Watch Target posted a slight Q2 beat, but price action says the leadership shift is the real catalyst. Here’s how to trade the reaction—because in the short term, Target CEO change overshadows earnings....
by ADRIAN FREDERICK MANZ Manz | Aug 20, 2025 | The Doctor's Dose
Meme Stock Pump-and-Dump Scams: A Day Trader’s Survival Guide In July, a fresh wave of meme-stock “ramps” rocketed thinly traded microcaps before collapsing just as fast—leaving billions in paper wealth erased and a trail of retail accounts blown up. Here’s what...
by ADRIAN FREDERICK MANZ Manz | Aug 20, 2025 | The Doctor's Dose
Advance Auto Parts (AAP) After Earnings: A Deeper Dive and Day-Trading Playbook Advance Auto Parts posted an EPS beat but guided 2025 lower as interest expense rises following a $1.95B notes offering. The stock’s third straight double-digit post-earnings move makes...
by ADRIAN FREDERICK MANZ Manz | Aug 19, 2025 | The Doctor's Dose
Oracle’s AI Rally Pauses: A Deeper Dive with Day-Trading Setups Oracle (ORCL) slipped more than 4% to ~238 after a torrid June–July run that peaked at 260.87. Price is now decisively below the 21-day moving average while still hovering a few percent above the 50-day,...
by ADRIAN FREDERICK MANZ Manz | Aug 19, 2025 | The Doctor's Dose
Merck Keytruda Medicare Delay: What It Means for Day Traders The recent tweak to Medicare’s drug price negotiation program has given Merck (MRK) a brief lifeline. While long-term investors are debating whether the change truly softens the looming Keytruda patent...
